| DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy KA Olaussen, A Dunant, P Fouret, E Brambilla, F André, V Haddad, ... New England Journal of Medicine 355 (10), 983-991, 2006 | 2326 | 2006 |
| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1817 | 2020 |
| Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions S Lev, H Moreno, R Martinez, P Canoll, E Peles, JM Musacchio, ... Nature 376 (6543), 737-745, 1995 | 1659 | 1995 |
| Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy C Denkert, G von Minckwitz, S Darb-Esfahani, B Lederer, BI Heppner, ... The lancet oncology 19 (1), 40-50, 2018 | 1649 | 2018 |
| A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation I Dikic, G Tokiwa, S Lev, SA Courtneidge, J Schlessinger Nature 383 (6600), 547-550, 1996 | 1202 | 1996 |
| A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors M Filipits, M Rudas, R Jakesz, P Dubsky, F Fitzal, CF Singer, O Dietze, ... Clinical Cancer Research 17 (18), 6012-6020, 2011 | 776 | 2011 |
| RNA interference screen for human genes associated with West Nile virus infection MN Krishnan, A Ng, B Sukumaran, FD Gilfoy, PD Uchil, H Sultana, ... Nature 455 (7210), 242-245, 2008 | 595 | 2008 |
| Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma AS Berghoff, B Kiesel, G Widhalm, O Rajky, G Ricken, A Wöhrer, ... Neuro-oncology 17 (8), 1064-1075, 2015 | 583 | 2015 |
| Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer M Kaufmann, G Von Minckwitz, EP Mamounas, D Cameron, LA Carey, ... Annals of surgical oncology 19, 1508-1516, 2012 | 569 | 2012 |
| Thrust geometries and deep structure of the outer and lesser Himalaya, Kumaon and Garhwal (India): Implications for evolution of the Himalayan fold‐and‐thrust belt P Srivastava, G Mitra Tectonics 13 (1), 89-109, 1994 | 514 | 1994 |
| Effect of Achyranthes aspera on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila YV Rao, BK Das, P Jyotyrmayee, R Chakrabarti Fish & Shellfish Immunology 20 (3), 263-273, 2006 | 509 | 2006 |
| Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal … M Gnant, M Filipits, R Greil, H Stoeger, M Rudas, Z Bago-Horvath, ... Annals of oncology 25 (2), 339-345, 2014 | 444 | 2014 |
| T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers A Rody, U Holtrich, L Pusztai, C Liedtke, R Gaetje, E Ruckhaeberle, ... Breast Cancer Research 11, 1-13, 2009 | 444 | 2009 |
| ERCC1 isoform expression and DNA repair in non–small-cell lung cancer L Friboulet, KA Olaussen, JP Pignon, FA Shepherd, MS Tsao, S Graziano, ... New England Journal of Medicine 368 (12), 1101-1110, 2013 | 428 | 2013 |
| Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the GeparSixto randomized clinical trial E Hahnen, B Lederer, J Hauke, S Loibl, S Kröber, A Schneeweiss, ... JAMA oncology 3 (10), 1378-1385, 2017 | 405 | 2017 |
| Non-vesicular lipid transport by lipid-transfer proteins and beyond S Lev Nature reviews Molecular cell biology 11 (10), 739-750, 2010 | 402 | 2010 |
| The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients P Dubsky, JC Brase, R Jakesz, M Rudas, CF Singer, R Greil, O Dietze, ... British journal of cancer 109 (12), 2959-2964, 2013 | 380 | 2013 |
| Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. UWE Holtrich, G Wolf, A Bräuninger, T Karn, B Böhme, ... Proceedings of the National Academy of Sciences 91 (5), 1736-1740, 1994 | 366 | 1994 |
| Activation of Pyk2 by stress signals and coupling with JNK signaling pathway G Tokiwa, I Dikic, S Lev, J Schlessinger Science 273 (5276), 792-794, 1996 | 364 | 1996 |
| Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non–small-cell lung cancer in four trials of … FA Shepherd, C Domerg, P Hainaut, PA Jänne, JP Pignon, S Graziano, ... Journal of clinical oncology 31 (17), 2173, 2013 | 363 | 2013 |
